Bonraybio Co., Ltd. (TPE:6955)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
165.50
-6.50 (-3.78%)
At close: Mar 9, 2026
30.36%
Market Cap 4.10B
Revenue (ttm) 287.10M
Net Income (ttm) 96.28M
Shares Out 24.80M
EPS (ttm) 3.92
PE Ratio 42.20
Forward PE n/a
Dividend 1.30 (0.76%)
Ex-Dividend Date Mar 19, 2026
Volume 10,011
Average Volume 13,803
Open 168.00
Previous Close 172.00
Day's Range 165.50 - 168.00
52-Week Range 104.35 - 186.96
Beta 0.03
RSI 57.32
Earnings Date Feb 26, 2026

About Bonraybio

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was found... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2015
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2024, Bonraybio's revenue was 222.88 million, an increase of 39.61% compared to the previous year's 159.64 million. Earnings were 68.37 million, an increase of 165.75%.

Financial Statements

News

There is no news available yet.